Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
My Top 5 Dividend Stocks For The 2nd Half Of 2022 (My First 5 Picks Beat The S&P By 10%)
07:51pm, Monday, 01'st Aug 2022
The five stocks I picked at the beginning of the year collectively outperformed the S&P 500 by roughly 10%, excluding dividends. On average, my five picks for the latter half of the year have bigger y
Looking for a Growth Stock? 3 Reasons Why Merck (MRK) is a Solid Choice
01:55pm, Monday, 01'st Aug 2022
Merck (MRK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Merck And AbbVie Q2: Pipeline And Dividends In Focus
08:38am, Monday, 01'st Aug 2022
Both Merck and AbbVie reported their Q2 earnings last week, and this article provides a review of their earnings. We like both given their strong pipeline and safe dividends.
Merck & Co, Inc. (MRK) CEO Robert Davis on Q2 2022 Results - Earnings Call Transcript
01:32pm, Thursday, 28'th Jul 2022
Merck & Co, Inc. (NYSE:MRK ) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Peter Dannenbaum - VP, IR Robert Davis - President, CEO & Director Caroline Litchfield - EVP
Merck, Pfizer stocks under pressure after reporting earnings
10:37am, Thursday, 28'th Jul 2022
Yahoo Finance Live anchors Julie Hyman, Brian Sozzi and Brad Smith discuss earnings for Merck and Pfizer.
Merck (MRK) Surpasses Q2 Earnings and Revenue Estimates
09:23am, Thursday, 28'th Jul 2022
Merck (MRK) delivered earnings and revenue surprises of 11.98% and 5.36%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Merck Eyes 50-Day Line As Profit Triples And Keytruda Passes $5 Billion Mark
09:06am, Thursday, 28'th Jul 2022
Merck stock rose moderately on Thursday after reporting adjusted income of $1.87 per share on $14.59 billion in second-quarter sales. The post Merck Eyes 50-Day Line As Profit Triples And Keytruda Pas
7 Stocks to Buy on the Dip
09:04am, Thursday, 28'th Jul 2022
The U.S. equities market remains in a dip no matter how you define it. Year-to-date, the Dow Jones Industrial Average is off by 12%.
Merck stock ticks up after profit more than triples to beat expectations
06:45am, Thursday, 28'th Jul 2022
Shares of Merck & Co. Inc. MRK, -0.07% edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year
Merck Tops Profit Estimates on Strong Keytruda and Gardasil Sales
06:40am, Thursday, 28'th Jul 2022
The drug giant said it expects 2022 sales of between $57.5 billion and $58.5 billion.
Merck quarterly profit tops Wall Street view on strong Keytruda sales
06:32am, Thursday, 28'th Jul 2022
Merck & Co on Thursday reported higher-than-expected second-quarter earnings and revenue on strong sales of its blockbuster cancer drug Keytruda.
Top 5 Stocks To Buy For Second Half 2022
02:01pm, Wednesday, 27'th Jul 2022
Inflation remains on fire, CPI reached 9.1% and the Fed continues to hike rates to curb inflation. Negative sentiment has investors hyper-sensitive to declines in their portfolios. With fear moving th
Why Merck Offers Plenty Of Value At Current Levels
09:00am, Wednesday, 27'th Jul 2022
Merck is a strong pharmaceutical company with blockbuster drugs and a promising coronavirus treatment. Its robust top-line growth should more than support its pipeline, including 8 new potential drugs
Seagen Tips Its Hand In Bladder Cancer, But Is It Enough To Woo Merck?
10:17am, Tuesday, 26'th Jul 2022
Nearly two-thirds of bladder cancer patients responded to a combination from Seagen and Merck, leading SGEN stock to jump Tuesday. The post Seagen Tips Its Hand In Bladder Cancer, But Is It Enough To
3 Top Defensive Stocks On The Eve Of The July Fed Meeting
06:00am, Tuesday, 26'th Jul 2022
The July FOMC meeting is this week, and many investors are on edge as the markets remain in flux following months of rate hikes that led to negative sentiment. With CPI reaching 9.1%, the likelihood o
